Drugmakers Look To Nix Non-Insulin Claims From AG Suit

By Jared Foretek · June 10, 2024, 5:58 PM EDT

Novo Nordisk, Eli Lilly and Sanofi-Aventis asked the federal judge overseeing a diabetes drug price-fixing multidistrict litigation to rule for drugmakers on Mississippi's claims the pricing for GLP-1s is illegal, saying...

To view the full article, register now.